Package 75834-221-00

{"route": ["ORAL"], "spl_id": "45806c19-4811-987e-e063-6394a90aa8fa", "openfda": {"nui": ["N0000008486", "N0000175751", "N0000185506", "N0000191266", "N0000187064", "N0000185507", "N0000185607"], "upc": ["0375834220017", "0375834221014", "0375834220000", "0375834221007"], "unii": ["33CM23913M"], "rxcui": ["197441", "308979"], "spl_set_id": ["e68998cb-5f91-4d7e-85a6-555efb8b0384"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Mood Stabilizer [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]"], "manufacturer_name": ["NIVAGEN PHARMACEUTICALS, INC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1000 TABLET in 1 BOTTLE (75834-221-00)", "package_ndc": "75834-221-00", "marketing_start_date": "20200421"}, {"sample": false, "description": "100 TABLET in 1 BOTTLE (75834-221-01)", "package_ndc": "75834-221-01", "marketing_start_date": "20200421"}], "brand_name": "Carbamazepine", "product_id": "75834-221_45806c19-4811-987e-e063-6394a90aa8fa", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "75834-221", "generic_name": "Carbamazepine", "labeler_name": "NIVAGEN PHARMACEUTICALS, INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Carbamazepine", "active_ingredients": [{"name": "CARBAMAZEPINE", "strength": "200 mg/1"}], "application_number": "ANDA207798", "marketing_category": "ANDA", "marketing_start_date": "20200421", "listing_expiration_date": "20261231"}